These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 37334870)

  • 1. Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation.
    Bazinet A; Kantarjian H; Arani N; Popat U; Bataller A; Sasaki K; DiNardo CD; Daver N; Yilmaz M; Abbas HA; Short NJ; Issa G; Jabbour E; Pierce SA; Chen J; Garcia R; Konopleva M; Garcia-Manero G; Alousi A; Shpall EJ; Champlin RE; Borthakur G; Ravandi F; Kadia T
    Am J Hematol; 2023 Sep; 98(9):1383-1393. PubMed ID: 37334870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation.
    Short NJ; Ong F; Ravandi F; Nogueras-Gonzalez G; Kadia TM; Daver N; DiNardo CD; Konopleva M; Borthakur G; Oran B; Al-Atrash G; Mehta R; Jabbour EJ; Yilmaz M; Issa GC; Maiti A; Champlin RE; Kantarjian H; Shpall EJ; Popat U
    Blood Adv; 2023 Jul; 7(14):3573-3581. PubMed ID: 37104058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure.
    Short NJ; Venugopal S; Qiao W; Kadia TM; Ravandi F; Macaron W; Dinardo CD; Daver N; Konopleva M; Borthakur G; Shpall EJ; Popat U; Champlin RE; Mehta R; Al-Atrash G; Oran B; Jabbour E; Garcia-Manero G; Issa GC; Montalban-Bravo G; Yilmaz M; Maiti A; Kantarjian H
    J Hematol Oncol; 2022 Jan; 15(1):12. PubMed ID: 35093134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation.
    Senapati J; Kantarjian HM; Bazinet A; Reville P; Short NJ; Daver N; Borthakur G; Bataller A; Jabbour E; DiNardo C; Haddad F; Sasaki K; Popat U; Oran B; Alousi AM; Loghavi S; Shpall E; Garcia-Manero G; Ravandi F; Kadia TM
    Cancer; 2024 Oct; 130(19):3333-3343. PubMed ID: 38809547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukemia: Incidence, transplantation and survival through Italian administrative healthcare data.
    Calabria S; Ronconi G; Dondi L; Piccinni C; Pedrini A; Esposito I; Addesi A; Rossi G; Ferrara F; Venditti A; Martini N
    Tumori; 2023 Oct; 109(5):496-503. PubMed ID: 36896466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and genetic dynamics of acute myeloid leukemia at first relapse.
    Bataller A; Kantarjian H; Bazinet A; Kadia T; Daver N; DiNardo CD; Borthakur G; Loghavi S; Patel K; Tang G; Sasaki K; Short NJ; Yilmaz M; Issa GC; Alvarado Y; Montalban-Bravo G; Maiti A; Abbas HA; Takahashi K; Pierce S; Jabbour E; Garcia-Manero G; Ravandi F
    Haematologica; 2024 May; ():. PubMed ID: 38695144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go?
    Marvin-Peek J; Gilbert JS; Pollyea DA; DiNardo CD
    Am J Hematol; 2024 Sep; 99(9):1790-1801. PubMed ID: 39016070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of older patients with acute myelogenous leukaemia without allogenic stem cell transplantation at Akershus University Hospital].
    Storlien T; Dahm AEA
    Tidsskr Nor Laegeforen; 2023 Oct; 143(15):. PubMed ID: 37874067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing Arsenic-Containing Qinghuang Powder and Low-Intensity Chemotherapy in Elderly Patients with Acute Myeloid Leukemia.
    Wu YH; Xiao HY; Quan RC; Tang XD; Liu WY; Lyu Y; Chen Z; Liu C; Hu XM
    Chin J Integr Med; 2023 Sep; 29(9):832-837. PubMed ID: 37222831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Status on Management of Primary Plasma Cell Leukemia.
    Gong Z; Khosla M; Vasudevan S; Mohan M
    Curr Oncol Rep; 2024 Sep; 26(9):1104-1112. PubMed ID: 38954316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First glowing animals lit up the oceans half a billion years ago.
    Kreier F
    Nature; 2024 Apr; ():. PubMed ID: 38658719
    [No Abstract]   [Full Text] [Related]  

  • 12. Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia.
    Senapati J; Urrutia S; Loghavi S; Short NJ; Issa GC; Maiti A; Abbas HA; Daver NG; Pemmaraju N; Pierce S; Chien KS; Sasaki K; Kadia TM; Hammond DE; Borthakur G; Patel K; Ravandi F; Kantarjian HM; Garcia-Manero G; DiNardo CD
    Blood; 2023 Nov; 142(19):1647-1657. PubMed ID: 37441846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax.
    Gaur T; Poddutoori R; Khare L; Bagal B; Rashmi S; Patkar N; Tembhare P; Pg S; Shetty D; Dutt A; Zhang Q; Konopleva M; Platzbeckar U; Gupta S; Samajdar S; Ramchandra M; Khattry N; Hasan SK
    J Exp Clin Cancer Res; 2023 Jul; 42(1):186. PubMed ID: 37507802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML.
    Xie J; Bao X; Xue SL; Shen H; Cen J; Yao L; Pan J; Zhu M; Liu D; Hu X; Wu Q; Zhang J; Dai H; Cao Y; He X; Tang X; Sun AN; Wang Y; Fu J; Qiu H; Yang X; Chen S; Wu D
    Blood; 2023 Oct; 142(15):1323-1327. PubMed ID: 37478399
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimising maintenance therapy after transplantation: sorafenib's role in patients with FLT3-ITD acute myeloid leukaemia.
    Yilmaz M; Daver N
    Lancet Haematol; 2023 Aug; 10(8):e559-e561. PubMed ID: 37532412
    [No Abstract]   [Full Text] [Related]  

  • 16. Cigarette smoke exposure accelerates AML progression in FLT3-ITD models.
    Figueroa M; Ma H; Alfayez M; Morales-Mantilla DE; Wang F; Lu Y; Estecio MR; King KY; Kleinerman E; Moghaddam SJ; Daver N; Andreeff M; Konopleva M; DiNardo C; Chandra J
    Blood Adv; 2023 Nov; 7(21):6624-6629. PubMed ID: 37486624
    [No Abstract]   [Full Text] [Related]  

  • 17. Venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment.
    Naka R; Kondo T; Nishikubo M; Muranushi H; Ueda Y; Oka T; Wada F; Kanda J; Yamamoto S; Watanabe M; Okada S; Imada K; Nakabo Y; Mizutani Y; Nannya Y; Ogawa S; Ishikawa T
    Am J Hematol; 2023 Sep; 98(9):E251-E254. PubMed ID: 37381699
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of outcomes for patients with acute myeloid leukemia undergoing haploidentical stem cell transplantation in first and second complete remission.
    Yu WJ; Sun YQ; Xu LP; Zhang XH; Liu KY; Huang XJ; Wang Y
    Ann Hematol; 2023 Aug; 102(8):2241-2250. PubMed ID: 37344697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 Mutations.
    Selheim F; Aasebø E; Reikvam H; Bruserud Ø; Hernandez-Valladares M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791118
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.